Navigation Links
MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
Date:10/3/2007

Broadens late-stage product development portfolio building on lead product

candidate EcoNail in Phase 2 trial for onychomycosis

WELLESLEY HILLS, Mass., Oct. 3 /PRNewswire-FirstCall/ -- MacroChem Corporation (OTC Bulletin Board: MACM) today announced that it has exercised the option it acquired in July, 2007 to acquire exclusive worldwide license rights for drug uses of pexiganan, a novel, small peptide anti-infective for treatment of patients with mild diabetic foot infection (DFI), from Genaera Corporation.

"We believe this is a unique opportunity for MacroChem to broaden its product portfolio with a product that has already completed two Phase 3 clinical trials and that fits our strategic focus and complements our lead product candidate, EcoNail(R) for treatment of nail fungus," stated Robert J. DeLuccia, President and CEO of MacroChem. "Both drugs would treat diseases of the foot predominantly treated by the same prescribing specialists, namely podiatrists. Both EcoNail and pexiganan are potentially of interest to a larger number of physician specialists and primary care physicians. MacroChem would ultimately be seeking a partner for marketing to those groups while retaining rights to market to selected physician specialists."

In clinical trials previously conducted by Genaera, over 1000 human subjects were exposed to pexiganan without safety concerns, including 418 patients who received pexiganan in two Phase 3 clinical trials submitted in a New Drug Application to the U.S. Food and Drug Administration (FDA) in 1998. The primary clinical endpoint of one of the two Phase 3 trials was judged by the FDA to have been achieved. The other Phase 3 clinical trial, which did not meet its specified endpoint, provided strong supportive data indicative of the clinical benefit of pexiganan. At that time, difficulties with Chemistry Manufacturing & Controls (CMC) and an FDA request for one additional controlled trial precluded approval. Ma
'/>"/>

SOURCE MacroChem Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
2. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
3. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
4. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
5. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
6. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
7. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
8. Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory Compound, Shows Efficacy in Psoriasis
9. Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Societys Annual Meeting
10. Encouraging Clinical Activity of GSKs Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer
11. Clinical Data on ARIADs Novel mTOR Inhibitor, AP23573, To Be Presented at the ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... CAMBRIDGE, Mass. , April 24, 2015 /PRNewswire/ ... that BLU-554, a selective and potent inhibitor of ... anti-tumor activity in models of hepatocellular carcinoma (HCC) ... targeted therapeutic candidate, BLU-554 induced complete tumor regression ... of an FGFR4-activating ligand at the highest dose ...
(Date:4/23/2015)... (NYSE: RMD ) today announced results for its ... was $422.5 million, a 6 percent increase compared to ... increase on a constant currency basis).  Net income was ... the quarter ended March 31, 2014.  Diluted earnings per ... 2 percent compared to the quarter ended March 31, ...
(Date:4/23/2015)... 23, 2015  Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... first quarter financial results on Thursday, May 7, 2015, ... will host a live audio webcast immediately following the ... first quarter 2015 financial results and provide a business ... the live audio webcast via the Investors & Media ...
Breaking Medicine Technology:Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 2Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 3ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 11ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 12ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 13Jazz Pharmaceuticals to Report 2015 First Quarter Financial Results on May 7, 2015 2
... STOCKHOLM , June 29, ... Karolinska Development,s portfolio companies, to,Pearson where it will become part ... receive an up front payment, as,well as tiered royalties up ... Cogmed,sales. Karolinska Development holds 51.83 percent of Cogmed. Pearson will,take ...
... June 29 Pfizer Inc. (NYSE: PFE ) invites investors and ... investment analysts at 10 a.m. EDT on Tuesday, August 3, 2010 . ... in the company,s Second Quarter 2010 Performance Report, to be issued that morning. , ... (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO ) , , ...
Cached Medicine Technology:Karolinska Development to Divest Portfolio Company 2Pfizer Invites Public to View and Listen to Webcast of August 3 Conference Call With Analysts 2
(Date:4/25/2015)... April 25, 2015 Carinsurancequotesinfo.com has released ... low cost auto insurance for flatbed trucks. ... goods and sometimes other vehicles. They are mainly used ... The newly released blog post explains that by comparing ... trucks, vans and other commercial vehicles. , It is ...
(Date:4/25/2015)... Turks and Caicos Islands, BWI (PRWEB) April 25, 2015 ... International Airport (PLS) has celebrated three months of successfully ... reopening on January 5, 2015. , As part ... the interior of Providenciales airport was completely redesigned to ... has quickened up the process of getting out of ...
(Date:4/25/2015)... (PRWEB) April 25, 2015 The URO CENTER ... Blaivas has been chosen by the New York Academy of ... to medicine in the field of Urology. , Dr. Ferdinand ... his speciality, Genito-Urinary diseases. He was a man of ... field of urology. Not only did he devote his ...
(Date:4/25/2015)... For thirteen years, the Twin Cities DI Day has ... the nation! This year, on May 5th, 2015, Secura Consultants ... DI Day on the road by supporting the first ever ... DIA, CLTC, Chief Executive Officer at Secura Consultants and co-creator ... by stating, "The first Twin Cities DI Day was a ...
(Date:4/24/2015)... 24, 2015 Multi Customer Discount , ... pumping ( http://www.zeitersseptics.com/multi-customer-discount.html ) of 1000-1500 gallons in Zeiter's ... program. This does not include any Dig fees, or ... per person. If someone is part of this group ... totaling approximately 2500 gallons or more, the cost would ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes for Flatbed Trucks Available Online! 2Health News:The Tuscany on Grace Bay Celebrates Providenciales Airport Expansion With Summer Specials to Travelers! 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3Health News:Secura Consultants Takes DI Day On The Road 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 3
... ... Thanks to an ever aging population, science and medicine are combining ... to combat what some believe is a genetically predisposed aging process in ... aging, longevity practices for diet, exercise, appearance and methods to improve overall ...
... ... until now, was popularly known as motivational words which is also known to some as, ... ... Akande speaking at the launching of his newly published book in London, UK on Thursday, ...
... ... ... annual "Top Doctors" issue, Westchester magazine included Dr. John Stangel as a lead fertility ... Medical Director of Reproductive Medicine Associates of Connecticut (RMACT) and has his office in Rye, ...
... ... TeezITNow.com will be focusing on the importance of family communications and promoting the value of ... ... safe sex should be top priority for parents this holiday season, according to Robert Moore, ...
... detection and treatment, study says , SUNDAY, Dec. 13 ... of cancer in everyday blood samples taken from patients, ... up biomarkers for prostate and breast cancers. Study co-author ... Nanoscience and Quantum Engineering in New Haven, Conn., said ...
... for coping with common scenarios , SATURDAY, Dec. 12 ... times, dysfunctional families and countless other factors, the holidays ... But there are ways to cope with the various ... according to Dr. Laura Miller, director of women,s mental ...
Cached Medicine News:Health News:Launch of ImmortalHumans.com as a Result of Humankind's Drive to Cure Aging and Become Biologically Immortal Within this Century 2Health News:Encouragement Words Takes on a New Terminology as Myeexpert Gifts Books, and Offers Free Counselling 2Health News:RMA of CT Doctor Named One of Westchester Magazine's 'Best MDs' 2Health News:RMA of CT Doctor Named One of Westchester Magazine's 'Best MDs' 3Health News:This Holiday Season Give Your Children the Gift that Saves Lives: Safer Sex 2Health News:'Nanosensors' Spot Early Signs of Cancer 2Health News:How to Attack Holiday Stress Head-On 2
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTT/1P chairs are recommended for the ... room, static control, health care and ...
... chairs with concave seats and ... • Select options like seats, ... glides. • BTT/1P chairs are ... industry, education, laboratory, clean room, ...
... chairs with concave seats and ... • Select options like seats, ... glides. • BTT/1P chairs are ... industry, education, laboratory, clean room, ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... the BE Series for top performance ... industry, education, laboratory, clean room, static ...
Medicine Products: